Skip to main content
Premium Trial:

Request an Annual Quote

And the Magic Eight Ball Says ... 28.2

Over at A Blog Around the Clock, Coturnix has a post on a recent editorial that calls into question the way impact factors are calculated. The editorial, published in the Journal of Cell Biology and penned by heads of that publication, the Journal of Experimental Medicine, and Rockefeller University Press, says that a number of subjective factors affect the calculations, such as publishers' ability to negotiate for better rankings. Blogger Coturnix says, "Apparently, it is really a magic number calculated in a mysterious way, not in the way that [Thomson] Scientific claims they do it."

Still, GTO would love to see a source for this that didn't have a connection to the very journals being affected by the impact factor process. Surely some unaffiliated number-crunchers would be interested in performing the audit?

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.